The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines

被引:104
作者
MacRae, V. E. [1 ]
Farquharson, C.
Ahmed, S. F.
机构
[1] Roslin Inst, Bone Biol Grp, Div Gene Funct & Dev, Edinburgh EH25 9PS, Midlothian, Scotland
[2] Royal Hosp Sick Children, Bone & Endocrine Res Grp, Glasgow G3 8SJ, Lanark, Scotland
关键词
D O I
10.1677/joe.1.06609
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Childhood chronic inflammatory disease can be associated with transient and permanent growth retardation. This study examined the potential for spontaneous growth recovery following pro-inflammatory cytokine exposure. Murine ATDC5 chondrogenic cells and postnatal metatarsals were exposed to interleukin (IL)-1 beta, IL-6 and tumour necrosis factor-alpha (TNF alpha), and their growth and proliferative capacity were determined following recovery. TNF alpha and IL-1 beta reduced chondrocyte proliferation and aggrecan and collagen types II and X expression at minimum concentrations of 10ng/ml and 0.1ng/ml respectively. TNF alpha, but not IL-1 beta exposure led to increased caspase-3 activity and altered cellular morphology, consistent with reduced viability. Cytokine exposure particularly inhibited proteoglycan synthesis. This effect was dose and duration dependent. Compared with the control, IL-1 beta and TNF alpha led to a 71% and 45% reduction in metatarsal growth after 8 days of exposure respectively (P < 0.05). An additive effect of IL-1 beta combined with TNF alpha was observed (110% decrease; P < 0.05). Metatarsals exposed to IL-1 beta or TNF alpha individually for a 2-day period, and allowed to recover spontaneously in the absence of cytokines for a further 6 days, showed normal growth trajectories. In combination, growth was 59% lower (P < 0.01) compared with control metatarsals at the end of the recovery period. Exposure to the combination for 4 days followed by a 4-day recovery period resulted in 87% decrement compared with controls (P < 0.05). IL-6 did not alter any parameter studied. IL-1 beta and TNF alpha exert diverse inhibitory effects on ATDC5 chondrocyte dynamics and metatarsal growth. The extent of recovery following cytokine exposure depends on the duration of exposure, and may be incomplete following longer periods of exposure.
引用
收藏
页码:319 / 328
页数:10
相关论文
共 44 条
[1]
Induction of apoptosis in chondrocytes by tumor necrosis factor-alpha [J].
Aizawa, T ;
Kon, T ;
Einhorn, TA ;
Gerstenfeld, LC .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2001, 19 (05) :785-796
[2]
Adult height in patients with early onset of Crohn's disease [J].
Alemzadeh, N ;
Rekers-Mombarg, LTM ;
Mearin, ML ;
Wit, JM ;
Lamers, CBHW ;
van Hogezand, RA .
GUT, 2002, 51 (01) :26-29
[3]
A CHONDROGENIC CELL-LINE DERIVED FROM A DIFFERENTIATING CULTURE OF AT805 TERATOCARCINOMA CELLS [J].
ATSUMI, T ;
MIWA, Y ;
KIMATA, K ;
IKAWA, Y .
CELL DIFFERENTIATION AND DEVELOPMENT, 1990, 30 (02) :109-116
[4]
Ballinger AB, 2000, GUT, V46, P694, DOI 10.1136/gut.46.5.695
[5]
BARON J, 1992, AM J PHYSIOL, V263, pE489
[6]
BATEMAN JF, 1996, EXTRACELLULAR MATRIX, V2, P22
[7]
LINEAR RELATIONSHIP BETWEEN THE VOLUME OF HYPERTROPHIC CHONDROCYTES AND THE RATE OF LONGITUDINAL BONE-GROWTH IN GROWTH PLATES [J].
BREUR, GJ ;
VANENKEVORT, BA ;
FARNUM, CE ;
WILSMAN, NJ .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1991, 9 (03) :348-359
[8]
IL-1β impairs insulin-like growth factor I-induced differentiation and downstream activation signals of the insulin-like growth factor I receptor in myoblasts [J].
Broussard, SR ;
McCusker, RH ;
Novakofski, JE ;
Strle, K ;
Shen, WH ;
Johnson, RW ;
Dantzer, R ;
Kelley, KW .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7713-7720
[9]
CROHNS-DISEASE IN CHILDREN - ASSESSMENT OF THE PROGRESSION OF DISEASE, GROWTH, AND PROGNOSIS [J].
CASTILE, RG ;
TELANDER, RL ;
COONEY, DR ;
ILSTRUP, DM ;
PERRAULT, J ;
VANHEERDEN, J ;
STICKLER, GB .
JOURNAL OF PEDIATRIC SURGERY, 1980, 15 (04) :462-469
[10]
Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3′-kinase signaling pathway [J].
Chrysis, D ;
Zaman, F ;
Chagin, AS ;
Takigawa, M ;
Sävendahl, L .
ENDOCRINOLOGY, 2005, 146 (03) :1391-1397